Pacific Biosciences of California (PACB) Stock Price

$1.17 0%

Sign up
to add to portfolio

AI Score

Sell

  • Alternative

    4

  • Fundamental

    2

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Pacific Biosciences of California, AI stock picks, stock alerts and much more.

Sign up

PACB AI Stock Analysis

AI stock analysis for PACB is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Pacific Biosciences of California (PACB) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Pacific Biosciences of California (PACB) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Pacific Biosciences of California (PACB), currently trading at $1.17, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About PACB

LSE

  • Pacific Biosciences of California, Inc.

  • Symbol

    PACB

  • Market

    NASDAQ

  • Industry

    Medical - Devices

  • Market Cap

    348.5M

Similar Stocks

ALGN Align Technology
ALGN		 $171.4
2.5%
6
IRTC iRhythm Technologies
IRTC		 $101
1%
6
DXCM Dexcom
DXCM		 $68.57
0.2%
5
BRKR Bruker
BRKR		 $36.28
3.9%
5
TMCI Treace Medical Concepts
TMCI		 $6.45
1.1%
4

News

PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million

PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million
April 9, 2025. globenewswire.com
PacBio Grants Equity Incentive Award to New Employee

PacBio Grants Equity Incentive Award to New Employee
April 4, 2025. globenewswire.com
Pacific Biosciences Names Jim Gibson Chief Financial Officer

Pacific Biosciences Names Jim Gibson Chief Financial Officer
March 27, 2025. marketwatch.com
Jim Gibson to join PacBio as Chief Financial Officer

Jim Gibson to join PacBio as Chief Financial Officer
March 27, 2025. globenewswire.com

PACB Alternative Data

Web Traffic

Pacific Biosciences of California receives an estimated 110744 monthly visitors to pacb.com.

  • Web Traffic

    110744

  • Change from Previous Month

    38.6%

  • 3 Month Change

    9.2%

  • YoY Change

    9.2%

News Mentions

Pacific Biosciences of California was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    0%

Reddit Mentions

Pacific Biosciences of California has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

Facebook Engagement

Pacific Biosciences of California has engaged 5 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    5

  • Daily Change

    25%

  • 1 Month Change

    400%

  • 3 Month Change

    0%

  • YoY Change

    0%

Youtube Subscribers

Pacific Biosciences of California has 5,890 subscribers on its main Youtube channel, up by 0.9% over the last month.

  • Youtube Subscribers

    5890

  • Daily Change

    0%

  • 1 Month Change

    0.9%

  • 3 Month Change

    2.1%

  • YoY Change

    2.1%

LinkedIn Followers

83,516 are following Pacific Biosciences of California on LinkedIn, up by 1.1% over the last month.

  • LinkedIn Followers

    83516

  • Daily Change

    0%

  • 1 Month Change

    1.1%

  • 3 Month Change

    3.8%

Job Postings

Pacific Biosciences of California has an estimated 7 open job postings, which is down -50% over the last month.

  • Job Postings

    7

  • Daily Change

    22.2%

  • 1 Month Change

    50%

  • 3 Month Change

    66.7%

  • YoY Change

    66.7%

Twitter Followers

Pacific Biosciences of California has 44,969 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.

  • Twitter Followers

    44969

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    1.2%

  • YoY Change

    1.2%

LinkedIn Employees

According to LinkedIn, Pacific Biosciences of California has 673 employees.

  • LinkedIn Employees

    673

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.4%

  • YoY Change

    0.4%

Business Outlook

According to employee reviews, the business outlook among employees at Pacific Biosciences of California is 19 out of 100 (very bearish).

  • Business Outlook

    19

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

PACB Financials

PACB Key Metrics

  • Total Revenue

    $39.2M

  • Net Income

    $3.6M

  • Earnings per Share

    $0.0126

  • Free cash flow

    -$32.3M

  • EBITDA

    -$122.7M

  • EBITDA Ratio

    -3.12722

  • Total Assets

    $1.3B

PACB 2-year Revenue & Income
PACB 2-year Free Cash Flow

PACB Technicals

PACB SMA
PACB RSI

FAQ

What's the current price of Pacific Biosciences of California (PACB) Stock?
The price of an Pacific Biosciences of California (PACB) share is $1.17.

What's the market cap of Pacific Biosciences of California?
The current market cap of Pacific Biosciences of California is 348.5M.

Should I buy or sell PACB?
Pacific Biosciences of California exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Pacific Biosciences of California a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Pacific Biosciences of California stock. There are several bearish signals and market challenges that could negatively impact Pacific Biosciences of California's future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Pacific Biosciences of California (PACB) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Pacific Biosciences of California stock right now, as the outlook appears bearish.

What are some stocks similar to Pacific Biosciences of California (PACB) that investors often compare it to?
Pacific Biosciences of California (PACB) is often compared to similar stocks such as Align Technology, iRhythm Technologies, Dexcom, Bruker and Treace Medical Concepts.

What is the forecast for Pacific Biosciences of California's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Pacific Biosciences of California's stock price to be around $1.1 in 2026. Starting from the current price of $1.17, this represents a 6.2% change in price, indicating a bearish outlook for the stock.

How to buy Pacific Biosciences of California (PACB) Stock?
Pacific Biosciences of California stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Pacific Biosciences of California shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.